- Quotient (NASDAQ:QTNT) FQ3 results:
- Revenues: $8.75M (+10.2%).
- Net Loss: ($29.76M) (+8%); Loss Per Share: ($0.29); As of December 31, 2020, cash and cash equivalents of $143.5M
- FY 2021 Guidance: Total product sales of Alba: $33.5M to $34M; Average monthly cash use for operations: $5M to $6M; CAPEX: $6M to $8M.
- Quotient shares down ~15% premarket.
- The company plans to submit its MosaiQ semi-quantitative COVID-19 antibody test for an FDA Emergency Use Authorization (EUA) in February 2021.
- Previously (Feb. 1): Quotient EPS beats by $0.01, beats on revenue